Tozuka, T., Seike, M., Minegishi, Y., Kitagawa, S., Kato, T., Takano, N., . . . Gemma, A. (2018). Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression. Onco Targets Ther.
استشهاد بنمط شيكاغوTozuka, Takehiro, et al. "Pembrolizumab and Salvage Chemotherapy in EGFR T790M-positive Non-small-cell Lung Cancer With High PD-L1 Expression." Onco Targets Ther 2018.
MLA استشهادTozuka, Takehiro, et al. "Pembrolizumab and Salvage Chemotherapy in EGFR T790M-positive Non-small-cell Lung Cancer With High PD-L1 Expression." Onco Targets Ther 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.